Medicare Enrolled

Dr. Charles Hollander, O.D.

Low Vision Rehabilitation Optometrist · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
25 W 43RD ST, New York, NY 10036
2129211888
In practice since 2005 (20 years)
NPI: 1518950799 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hollander from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hollander? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hollander

Dr. Charles Hollander is a low vision rehabilitation optometrist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hollander performed 1,034 Medicare services across 954 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hollander received a total of $1,584 from 16 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in low vision rehabilitation optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hollander is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in NY $1,584 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,034
Medicare services
Top 18% in NY for low vision rehabilitation optometrist
954
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~52 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
317 $101 $165
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
219 $30 $95
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
106 $79 $115
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
94 $34 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
76 $136 $214
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
70 $31 $146
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
42 $64 $135
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
39 $114 $200
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $44 $115
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
19 $99 $165
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
17 $49 $90
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
13 $71 $178
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,584
Total received (2018-2024)
Avg $226/year across 7 years
Top 32% in NY for low vision rehabilitation optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
72
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,584 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$329
2023
$318
2022
$425
2021
$299
2020
$19
2019
$37
2018
$156

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$146
ABBVIE INC.
$78
BIOTISSUE HOLDINGS INC.
$62
Tarsus Pharmaceuticals, Inc.
$44
Top 3 companies account for 86.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$377
Allergan, Inc.
$153
SUN PHARMACEUTICAL INDUSTRIES INC.
$146
Sun Pharmaceutical Industries Inc.
$146
Alcon Vision LLC
$144
TISSUETECH, INC.
$143
Spark Therapeutics, Inc.
$125
BIOTISSUE HOLDINGS, INC.
$82
BIOTISSUE HOLDINGS INC.
$62
Tarsus Pharmaceuticals, Inc.
$44
Kala Pharmaceuticals, Inc.
$38
Bausch & Lomb Americas Inc.
$32
Bausch & Lomb, a division of Bausch Health US, LLC
$31
CooperVision Inc.
$21
BioTissue Holdings, Inc.
$21
Carl Zeiss Meditec AG
$19
Top 3 companies account for 42.7% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · BIOTRUE · Cequa · DAILIES · ILUX · INFUSE · INVELTYS · LUMIGAN · LUXTURNA · None Specified · Onefit Contact Lens · PROKERA · Precision 1 · RESTASIS MULTIDOSE · ULTRA · VUITY · XDEMVY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a low vision rehabilitation optometrist in New York?
Compare low vision rehabilitation optometrists in the New York area by procedure volume, costs, and industry payment transparency.
Browse low vision rehabilitation optometrists nearby

Geographic Context

Low vision rehabilitation optometrists within 10 mi
25
Per 100K population
1.5
County median income
$104,553
Nearest hospital
MOUNT SINAI WEST
0.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hollander is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hollander experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hollander performed 317 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hollander receive payments from pharmaceutical companies?
Yes. Dr. Hollander received a total of $1,584 from 16 companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hollander's costs compare to other low vision rehabilitation optometrists in New York?
Dr. Hollander's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hollander) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →